MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06616cam a2200889Ia 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocm55698114 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220204092147.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cnu|||uuuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
000428s2000 njua ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
YUS |
| Language of cataloging |
eng |
| Description conventions |
pn |
| Transcribing agency |
YUS |
| Modifying agency |
OCLCQ |
| -- |
N$T |
| -- |
YDXCP |
| -- |
CUV |
| -- |
CNTRU |
| -- |
GW5XE |
| -- |
IDEBK |
| -- |
OCLCQ |
| -- |
CUS |
| -- |
COO |
| -- |
OCLCQ |
| -- |
DAY |
| -- |
CSU |
| -- |
OCLCE |
| -- |
E7B |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCF |
| -- |
OCLCQ |
| -- |
EUW |
| -- |
EBLCP |
| -- |
OCLCQ |
| -- |
VT2 |
| -- |
OCLCA |
| -- |
OTZ |
| -- |
STF |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
BUF |
| -- |
OCLCO |
| -- |
CASUM |
| -- |
MERER |
| -- |
OCLCQ |
| -- |
U3W |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
AU@ |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
OCLCQ |
| -- |
OCLCA |
| -- |
YOU |
| -- |
CANPU |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
U3G |
| -- |
OCLCQ |
| -- |
HS0 |
| -- |
GW5XE |
| -- |
OCLCQ |
| -- |
OCLCA |
| -- |
OCLCQ |
| -- |
OCLCA |
| -- |
INARC |
| -- |
LIP |
| -- |
UWK |
| -- |
LVT |
| -- |
OCLCQ |
| -- |
OCLCO |
| 019 ## - |
|---|
| -- |
170923324 |
| -- |
272404966 |
| -- |
320977931 |
| -- |
607601026 |
| -- |
609216039 |
| -- |
642460017 |
| -- |
771201878 |
| -- |
964890217 |
| -- |
967621868 |
| -- |
985040241 |
| -- |
993980458 |
| -- |
994752151 |
| -- |
1005745819 |
| -- |
1017903143 |
| -- |
1045327336 |
| -- |
1050735327 |
| -- |
1058391109 |
| -- |
1078042827 |
| -- |
1078825082 |
| -- |
1078865312 |
| -- |
1081207077 |
| -- |
1086814679 |
| -- |
1097346321 |
| -- |
1109038093 |
| -- |
1120894777 |
| -- |
1164904491 |
| -- |
1166255116 |
| -- |
1203632364 |
| -- |
1228577401 |
| -- |
1229573900 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781592590834 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1592590837 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
128082073X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781280820731 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9786610820733 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
6610820732 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
9780896037359 |
| Qualifying information |
(alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
0896037355 |
| Qualifying information |
(alk. paper) |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1385/1592590837. |
| Source of number or code |
doi |
| 029 1# - (OCLC) |
|---|
| OCLC library identifier |
AU@ |
| System control number |
000061122826 |
| 029 1# - (OCLC) |
|---|
| OCLC library identifier |
NZ1 |
| System control number |
15211906 |
| 029 1# - (OCLC) |
|---|
| OCLC library identifier |
AU@ |
| System control number |
000069305056 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)55698114 |
| Canceled/invalid control number |
(OCoLC)170923324 |
| -- |
(OCoLC)272404966 |
| -- |
(OCoLC)320977931 |
| -- |
(OCoLC)607601026 |
| -- |
(OCoLC)609216039 |
| -- |
(OCoLC)642460017 |
| -- |
(OCoLC)771201878 |
| -- |
(OCoLC)964890217 |
| -- |
(OCoLC)967621868 |
| -- |
(OCoLC)985040241 |
| -- |
(OCoLC)993980458 |
| -- |
(OCoLC)994752151 |
| -- |
(OCoLC)1005745819 |
| -- |
(OCoLC)1017903143 |
| -- |
(OCoLC)1045327336 |
| -- |
(OCoLC)1050735327 |
| -- |
(OCoLC)1058391109 |
| -- |
(OCoLC)1078042827 |
| -- |
(OCoLC)1078825082 |
| -- |
(OCoLC)1078865312 |
| -- |
(OCoLC)1081207077 |
| -- |
(OCoLC)1086814679 |
| -- |
(OCoLC)1097346321 |
| -- |
(OCoLC)1109038093 |
| -- |
(OCoLC)1120894777 |
| -- |
(OCoLC)1164904491 |
| -- |
(OCoLC)1166255116 |
| -- |
(OCoLC)1203632364 |
| -- |
(OCoLC)1228577401 |
| -- |
(OCoLC)1229573900 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dlr |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QR187.3 |
| Item number |
.V33 2000 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QW 805 |
| Item number |
V1154 2000 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
071000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJCM. |
| Source |
bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615/.372 |
| Edition number |
21 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Vaccine adjuvants : |
| Remainder of title |
preparation methods and research protocols / |
| Statement of responsibility, etc. |
edited by Derek T. O'Hagan. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Totowa, N.J. : |
| Name of publisher, distributor, etc. |
Humana Press, |
| Date of publication, distribution, etc. |
2000. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (x, 342 pages) : |
| Other physical details |
illustrations |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Methods in molecular medicine ; |
| Volume/sequential designation |
v. 42 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Source of title; title from title screen. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
An overview of adjuvant use -- Harmful and beneficial activities of immunological adjuvants -- Freund's adjuvants -- Aluminum compounds as vaccine adjuvants -- Poly(lactice-coglycolide) microparticles as vaccine adjuvants -- Poly(methyl methacrylate) nanoparticles as vaccine adjuvants -- Aqueous formulation of adjuvant-active nonionic block copolymers -- Liposomes as immunological adjuvants and vaccine carriers -- Immunopotentiating reconstituted indluezna virosomes (IRIVs) -- Cochleates for induction of mucosal and systemic immune responses -- Virus-like particles as vaccine adjuvants -- The adjuvant MF59: a 10 year perspective -- Preparation of the syntex adjuvant formulation (SAF, SAF-m, SAF-1) -- The ISCOM technology -- QS-21 adjuvant -- MPL Immunostimulant: adjuvant formulations -- Cytokines as vaccine adjuvants: the use of interleukin-2 -- DNA as an adjuvant -- Transcutaneous immunizaation -- Mutant heat-lbile enterotoxins as adjuvants for CTL induction. |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Annotation |
| Expansion of summary note |
Derek T. O'Hagan and a team of expert vaccinologists and pharmacologists thoroughly describe the preparation, characterization, and evaluation of a wide range of alternative vaccine adjuvants for use in preclinical studies. Each chapter carefully reviews a single adjuvant, and suggests why a specific adjuvant might be preferred for a given antigen, depending on what type of immune response is desired. Alternate adjuvant choices are also presented so that researchers can choose those most efficacious for their specific purpose. Comprehensive and highly practical, Vaccine Adjuvants: Preparation Methods and Research Protocols provides an effective guide to making and using vaccine adjuvants. By closely following directions from the book, today's researchers will be able optimally to induce specific immune responses against different types of antigens and to selectively manipulate the immune response in a favorable way. |
| 506 ## - RESTRICTIONS ON ACCESS NOTE |
|---|
| Materials specified |
Use copy |
| Standardized terminology for access restriction |
Restrictions unspecified |
| Source of term |
star |
| Institution to which field applies |
MiAaHDL |
| 533 ## - REPRODUCTION NOTE |
|---|
| Type of reproduction |
Electronic reproduction. |
| Place of reproduction |
[Place of publication not identified] : |
| Agency responsible for reproduction |
HathiTrust Digital Library, |
| Date of reproduction |
2010. |
| Institution to which field applies |
MiAaHDL |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |
| Uniform Resource Identifier |
<a href="http://purl.oclc.org/DLF/benchrepro0212">http://purl.oclc.org/DLF/benchrepro0212</a> |
| Institution to which field applies |
MiAaHDL |
| 583 1# - ACTION NOTE |
|---|
| Action |
digitized |
| Time/date of action |
2010 |
| Jurisdiction |
HathiTrust Digital Library |
| Status |
committed to preserve |
| Source of term |
pda |
| Institution to which field applies |
MiAaHDL |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunological adjuvants. |
| 9 (RLIN) |
81582 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Vaccines. |
| 9 (RLIN) |
80811 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Vaccines. |
| 9 (RLIN) |
80811 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Adjuvants, Immunologic. |
| 9 (RLIN) |
956703 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunologic Factors. |
| 9 (RLIN) |
81584 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biological Products. |
| 9 (RLIN) |
81585 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Complex Mixtures. |
| 9 (RLIN) |
81586 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Physiological Effects of Drugs |
| 9 (RLIN) |
81587 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemicals and Drugs |
| 9 (RLIN) |
13222 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacologic Actions |
| 9 (RLIN) |
81588 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemical Actions and Uses |
| 9 (RLIN) |
80980 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL |
| General subdivision |
Pharmacology. |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
80262 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunological adjuvants. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00967992 |
| 9 (RLIN) |
81582 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Vaccines. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst01163573 |
| 9 (RLIN) |
80811 |
| 650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Wetenschappelijke technieken. |
| Source of heading or term |
gtt |
| 9 (RLIN) |
956704 |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 9 (RLIN) |
396 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
O'Hagan, Derek T. |
| 9 (RLIN) |
81591 |
| 776 1# - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Title |
Vaccine adjuvants |
| Record control number |
(DLC) 99088373 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Methods in molecular medicine ; |
| Volume number/sequential designation |
v. 42. |
| 9 (RLIN) |
79864 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590837">https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590837</a> |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3036834 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10181298 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
201294 |
| 938 ## - |
|---|
| -- |
Internet Archive |
| -- |
INAR |
| -- |
vaccineadjuvants0000unse |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
2625987 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
ATIST |